|
|
HL7 - Version 2.9.1 |
|
|
| Seq | Description | German Interpretation | Length | C.LEN | Table | r/o/c | Rep# | Item | Data Structure | Section |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Set ID | R | 03543 | SI | 3.4.21.1 | |||||
| 2 | Action Code | Aktionscode | 1..1 | 0206 | R | 00816 | ID | 3.4.21.2 | ||
| 3 | GSC Instance Identifier | C | 02524 | EI | 3.4.21.3 | |||||
| 4 | Sex Parameter for Clinical Use | 0828 | R | 02525 | CWE | 3.4.21.4 | ||||
| 5 | Validity Period | O | 02526 | DR | 3.4.21.5 | |||||
| 6 | Context | R | Y | 02527 | ERL | 3.4.21.6 | ||||
| 7 | Evidence | O | Y | 02528 | ERL | 3.4.21.7 | ||||
| 8 | Comment | O | 02529 | TX | 3.4.21.8 |
| Links to Other/Further HL7 Information | generated: Jul 06, 2024 (FO) | |||
| Health Level Seven, Int. (HQ) |
HL7 Germany HL7 Europe |
Frank Oemig's HL7 Site (Infos about the database) |
HL7-Experts Network | |